Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer

Table 2

The correlation of CYBRD1 expression and clinical pathological features in TCGA cohort (logistic regression).

Characteristics	Total (N)	Odds ratio (OR)	value
FIGO stage (stage III and stage IV versus stage I and stage II)	376	1.471 (1.039–2.072)	0.027
Primary therapy outcome (CR versus PD, SD, and PR)	308	0.719 (0.567–0.899)	0.005
Venous invasion (yes versus no)	105	1.187 (0.837–1.702)	0.337
Anatomic neoplasm subdivision (bilateral versus unilateral)	357	1.181 (0.966–1.445)	0.104
Lymphatic invasion (yes versus no)	149	1.074 (0.802–1.435)	0.628
Tumor residual (RD versus NRD)	335	1.114 (0.876–1.435)	0.628
Age (>60 versus ≤60)	376	1.022 (0.680–1.535)	0.917